Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 199-218
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.199
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.199
Figure 6 Changes in the Shannon index and Richness in patients of the two groups before and after treatment.
A: Changes in the Shannon index in patients of the two groups before and after treatment (no significant decrease); B: Changes in the Richness in patients of the two groups before and after treatment: (no significant decrease).
- Citation: Lv XY, Ding HG, Zheng JF, Fan CL, Li L. Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study. World J Gastroenterol 2020; 26(2): 199-218
- URL: https://www.wjgnet.com/1007-9327/full/v26/i2/199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i2.199